By Mr Christopher Steer

Journal articles

Colombo N; Biagioli E; Harano K; Galli F; Hudson E; Antill Y; Choi CH; Rabaglio M; Marmé F; Marth C; Parma G; Fariñas-Madrid L; Nishio S; Allan K; Lee YC; Piovano E; Pardo B; Nakagawa S; McQueen J; Zamagni C; Manso L; Takehara K; Tasca G; Ferrero A; Tognon G; Lissoni AA; Petrella M; Laudani ME; Rulli E; Uggeri S; Barretina Ginesta MP; Zola P; Casanova C; Arcangeli V; Antonuzzo L; Gadducci A; Cosio S; Clamp A; Persic M; McNeish I; Tookman L; Redondo Sanchez A; Baldini E; Palaia I; Benedetti Panici P; Takahashi N; Lombard J; Ardizzoia A; Bologna A; Herrero Ibáñez AM; Musolino A; Márquez Vázquez R; Pietzner K; Braicu E; Heinzelmann-Schwarz VA; Powell M; Yokoyama Y; Baron-Hay S; Abeni C; Martin Lorente C; Cueva JF; Trillsch F; Heitz F; Ataseven B; Petru E; Heubner ML; Sadozye AH; Dubey S; Tazbirkova A; Tiley S; Chrystal K; Kim SW; Fehr M; Scatchard K; Anand A; Taylor A; Watary H; Enomoto T; Yoshihara K; Selva-Nayagam S; Karki B; Harrison M; Wilkinson K; Goh J; Glasgow A; Chantrill L; Lee C; Bertolini A; Narducci F; Bellotti G; Fusco V; Aebi S; Del Grande M; Colombo I; Tokunaga H; Shigeta S; Goss G; Siow ZR; Steer C; Lin H, 2024, 'Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial', The Lancet Oncology, 25, pp. 1135 - 1146, http://dx.doi.org/10.1016/S1470-2045(24)00334-6

Loh KP; Liposits G; Arora SP; Neuendorff NR; Gomes F; Krok-Schoen JL; Amaral T; Mariamidze E; Biganzoli L; Brain E; Baldini C; Battisti NML; Frélaut M; Kanesvaran R; Mislang ARA; Papamichael D; Steer C; Rostoft S, 2024, 'Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group', ESMO Open, 9, http://dx.doi.org/10.1016/j.esmoop.2024.103657

Tuesley KM; Spilsbury K; Webb PM; Pearson SA; Donovan P; Coory MD; Steer CB; Stewart LM; Pandeya N; Protani MM; Dixon-Suen S; Marquart-Wilson L; Jordan SJ, 2024, 'Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyae108

Sivakumaran T; White M; Prall O; Mitchell C; Dijkstra C; Rebello R; Xu H; Vissers J; Grimmond S; Wong H-L; DeFazio A; Gao B; Singh MS; Collins IM; Steer CB; Warren MA; Karanth NV; Bowtell D; Tothill RW; Mileshkin LR, 2024, 'Clinical impact of molecular profiling in the national prospective cohort Solving Unknown Primary Cancer (SUPER) study.', Journal of Clinical Oncology, 42, pp. 3056 - 3056, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3056

Hodge O; Rasekaba T; Blackberry I; Steer CB, 2024, 'Age-friendly healthcare: integrating the 4Ms to enable age-friendly cancer care', Current Opinion in Supportive and Palliative Care, 18, pp. 9 - 15, http://dx.doi.org/10.1097/SPC.0000000000000687

Steer CB; Sattar S; Menjak I, 2024, 'Supportive and palliative care for older adults with cancer; facilitating person-centred, age friendly care', Current Opinion in Supportive and Palliative Care, 18, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000689

Burge ME; Espinoza D; Sjoquist KM; Siu DHW; Mercieca-Bebber R; Chantrill LA; Karapetis CS; Steer CB; Yip S; Cuff J; Winata S; Tie J; Thaker DA; Tebbutt NC, 2024, 'AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).', Journal of Clinical Oncology, 42, pp. 3535 - 3535, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3535

Kulatunga S; Rich S; Steer C; Rasekaba T; Webb N; Blackberry ID, 2023, 'FEAR OF CANCER RECURRENCE IN OLDER WOMEN IN REMISSION FROM GYNAECOLOGICAL CANCER IN REGIONAL AUSTRALIA', Innovation in Aging, 7, pp. 1042 - 1042, http://dx.doi.org/10.1093/geroni/igad104.3349

Blackberry ID; Rich S; Hodge O; Rasekaba T; Webb N; Steer C, 2023, 'THE ROLE OF AGE-FRIENDLY HEALTH CARE IN OLDER ADULTS WITH CANCER', Innovation in Aging, 7, pp. 198 - 198, http://dx.doi.org/10.1093/geroni/igad104.0651

Disalvo D; Moth E; Soo WK; Garcia MV; Blinman P; Steer C; Amgarth-Duff I; Power J; Phillips J; Agar M, 2023, 'The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review', Journal of Geriatric Oncology, 14, http://dx.doi.org/10.1016/j.jgo.2023.101585

Fernando M; Anton A; Weickhardt A; Azad AA; Uccellini A; Brown S; Wong S; Parente P; Shapiro J; Liow E; Torres J; Goh J; Parnis F; Steer C; Warren M; Gibbs P; Tran B, 2023, 'Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort', Journal of Geriatric Oncology, 14, http://dx.doi.org/10.1016/j.jgo.2023.101621

Tuesley KM; Spilsbury K; Webb PM; Protani MM; Dixon-Suen S; Pearson SA; Donovan P; Coory MD; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, 'Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older', Cancer Epidemiology, 86, http://dx.doi.org/10.1016/j.canep.2023.102444

Hall VG; Sim BZ; Lim C; Hocking C; Teo T; Runnegar N; Boan P; Heath CH; Rainey N; Lyle M; Steer C; Liu E; Doig C; Drummond K; Charles PGP; See K; Lim LL; Shum O; Bak N; Mclachlan SA; Singh KP; Laundy N; Gallagher J; Stewart M; Saunders NR; Klimevski E; Demajo J; Reynolds G; Thursky KA; Worth LJ; Spelman T; Yong MK; Slavin MA; Teh BW, 2023, 'COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study', The Lancet Regional Health - Western Pacific, 38, http://dx.doi.org/10.1016/j.lanwpc.2023.100824

Steer C; Rasekaba T; Owen K; Jayasuriya D; Kapur M; Young K; Webb N; Blackberry I, 2023, 'Geriatric Oncology in the Instagram Era: Feasibility and Acceptability Randomised Controlled Trial on Adopting PhotoVoice to Enable Empowerment, Patient-Centred Care, and Shared Decision Making—Study Protocol', Methods and Protocols, 6, http://dx.doi.org/10.3390/mps6040068

Yenson VM; Amgarth-Duff I; Brown L; Caperchione CM; Clark K; Cross A; Good P; Landers A; Luckett T; Philip J; Steer C; Vardy JL; Wong AK; Agar MR, 2023, 'Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study', Supportive Care in Cancer, 31, http://dx.doi.org/10.1007/s00520-023-07889-y

Dean AP; Price TJ; Sjoquist KM; Gebski V; Mumford J; Day F; Yip S; Bradshaw N; Jackson CGCA; Padinharakam S; Lee B; Burge ME; Tebbutt NC; Steer CB; Lomma C; Lam L; Lee J; Chantrill LA; Harris M, 2023, 'ASCEND: A randomised, double-blinded, phase II study of gemcitabine and nab‐paclitaxel with CEND‐1/LSTA1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma.', Journal of Clinical Oncology, 41, pp. TPS4197 - TPS4197, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps4197

Ananda S; Wang Y; Hong W; Richardson GE; Lombard JM; Goss G; Mileshkin LR; Steer CB; Lennon AM; McNally O; Douville CB; Popoli M; Ptak J; Silliman N; Dobbyn L; Papadopoulos N; Kinzler KW; Vogelstein B; Tie J; Gibbs P, 2023, 'Circulating tumor DNA (ctDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC).', Journal of Clinical Oncology, 41, pp. 5553 - 5553, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.5553

Soo WK; Yin V; Crowe J; Lane H; Steer CB; Dārziņš P; Davis ID, 2023, 'Integrated care for older people with cancer: a primary care focus', The Lancet Healthy Longevity, 4, pp. e243 - e245, http://dx.doi.org/10.1016/S2666-7568(23)00058-2

Sjoquist KM; Dobrovic A; Robledo K; Baron-Hay SE; Ananda S; McCarthy NJ; Goh JC; Murray N; Steer CB; Yip S; Mileshkin LR; Kondrashova O; Fink JL; Chang G; Bailey L; Lee Y; Zebic DS; Vandenberg CJ; Scott CL; Waring PM, 2023, 'Olaparib in HR-deficient (HRD), metastatic triple-negative breast cancer (TNBC) and relapsed ovarian cancer (ROC) without germline mutations in BRCA1 or BRCA2: Phase 2 EMBRACE trial.', Journal of Clinical Oncology, 41, pp. e15079 - e15079, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15079

Weppler AM; Da Meda L; Pires da Silva I; Xu W; Grignani G; Menzies AM; Carlino MS; Long GV; Lo SN; Nordman I; Steer CB; Lyle M; Trojaniello C; Ascierto PA; Lebbe C; Sandhu S, 2023, 'Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation', European Journal of Cancer, 183, pp. 109 - 118, http://dx.doi.org/10.1016/j.ejca.2023.01.016

Menjak IB; Sattar S; Steer C, 2023, 'Supportive and palliative care for older adults with cancer', Current Opinion in Supportive and Palliative Care, 17, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000633

Kelly R; Jensen A; Karunaratna N; Wong S; Shapiro J; Weickhardt A; Parente P; Azad AA; Uccellini A; Torres J; Parnis F; Goh J; Kwan EM; Brown S; Steer C; Warren M; Gibbs P; Tran B; Anton A, 2023, 'Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer', BJU International, 131, pp. 179 - 182, http://dx.doi.org/10.1111/bju.15930

Posner A; Sivakumaran T; Pattison A; Etemadmoghadam D; Thio N; Wood C; Fisher K; Webb S; Defazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Fellowes A; Fox SB; Hicks RJ; Schofield P; Bowtell D; Prall OWJ; Tothill RW; Mileshkin L, 2023, 'Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary', Journal for ImmunoTherapy of Cancer, 11, http://dx.doi.org/10.1136/jitc-2022-005809

Spilsbury K; Tuesley KM; Pearson SA; Coory MD; Donovan P; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, 'Perioperative Beta-Blocker Supply and Survival in Women with Epithelial Ovarian Cancer and a History of Cardiovascular Conditions', Journal of Clinical Oncology, 41, pp. 266 - 275, http://dx.doi.org/10.1200/JCO.22.00097

Posner A; Prall OWJ; Sivakumaran T; Etemadamoghadam D; Thio N; Pattison A; Balachander S; Fisher K; Webb S; Wood C; DeFazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Wright G; Williams S; George J; Hicks RJ; Boussioutas A; Gill AJ; Solomon BJ; Xu H; Fellowes A; Fox SB; Schofield P; Bowtell D; Mileshkin L; Tothill RW, 2023, 'A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary', Journal of Pathology, 259, pp. 81 - 92, http://dx.doi.org/10.1002/path.6022

Pereira-Salgado A; Anton A; Franchini F; Mahar RK; Kwan EM; Wong S; Shapiro J; Weickhardt A; Azad AA; Spain L; Gunjur A; Torres J; Parente P; Parnis F; Goh J; Steer C; Brown S; Gibbs P; Tran B; IJzerman M, 2023, 'Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?', Expert Review of Pharmacoeconomics and Outcomes Research, 23, pp. 231 - 239, http://dx.doi.org/10.1080/14737167.2023.2161048

Steer C; Webb N; Rich S; Rasekaba T; Engel B; Underhill C; Wright S; Blackberry I, 2023, 'Implementation of Enhanced Supportive Care for Older Adults at an Australian Regional Cancer Centre', Journal of Geriatric Oncology, 14, pp. S41 - S41, http://dx.doi.org/10.1016/s1879-4068(23)00339-9

Blackberry I; Steer C; Rasekaba T; Rich S; Webb N; Young K, 2022, 'IMPLEMENTING AND MEASURING IMPACT OF A FIVE-YEAR TRANSLATIONAL GERIATRIC ONCOLOGY RESEARCH PROGRAM', Innovation in Aging, 6, pp. 235 - 236, http://dx.doi.org/10.1093/geroni/igac059.934

Guccione L; Fisher K; Mileshkin L; Tothill R; Bowtell D; Quinn S; DeFazio A; Karapetis CS; Wilcken N; Singh M; Steer C; Gao B; Warren M; Collins IM; Karanth N; Bryant C; Schofield P, 2022, 'Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study', Supportive Care in Cancer, 30, pp. 8217 - 8229, http://dx.doi.org/10.1007/s00520-022-07228-7

Tuesley KM; Webb PM; Protani MM; Spilsbury K; Pearson S-A; Coory MD; Donovan P; Steer C; Stewart LM; Pandeya N; Jordan SJ, 2022, 'Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older (vol 114, djac050, 2022)', JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 114, pp. 1206 - 1206, http://dx.doi.org/10.1093/jnci/djac118

Tuesley KM; Webb PM; Protani MM; Spilsbury K; Pearson SA; Coory MD; Donovan P; Steer C; Stewart LM; Pandeya N; Jordan SJ, 2022, 'Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older', Journal of the National Cancer Institute, 114, pp. 878 - 884, http://dx.doi.org/10.1093/jnci/djac050

Tuesley KM; Webb PM; Protani MM; Spilsbury K; Pearson S-A; Coory MD; Donovan P; Steer C; Stewart LM; Pandeya N; Jordan SJ, 2022, 'Response to Lehrer and Rheinstein', JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, http://dx.doi.org/10.1093/jnci/djac083

Smith MR; Scher HI; Sandhu S; Efstathiou E; Lara PN; Yu EY; George DJ; Chi KN; Saad F; Ståhl O; Olmos D; Danila DC; Mason GE; Espina BM; Zhao X; Urtishak KA; Francis P; Lopez-Gitlitz A; Fizazi K; Parnis F; Joshua AM; Horvath LG; Steer C; Marx G; Gurney H; Ferguson T; Van Bruwaene S; Luyten D; Schatteman P; Lumen N; Dirix L; Goeminne JC; Gil T; Seront E; Vulsteke C; Kussumoto C; Franke FA; Martinelli de Oliveira FA; Pereira de Santana Gomes AJ; Pinczowski H; Preto DDA; Zucca LE; Borges GS; Murad AM; Fradet Y; Fleshner NE; Emmenegger U; Brasso K; Culine S; Thiery-Vuillemin A; Joly F; Fléchon A; Hilgers W; Eymard JC; Borchiellini D; Barthélémy P; Berger R; Leibowitz-Amit R; Mermershtain W; Rouvinov K; Peer A; Kovel S; Sella A; Lolkema MP; van den Eertwegh AJM; Voortman J; Aarts MJ; Gietema JA; Kim CS; Choi YD; Chung BH; Gafanov RA; Kopyltsov E; Usynin EA; Carles J; Mellado B; Maroto JP; García-Donás J; Rodríguez Moreno JF; Durán I; Pérez-Valderrama B; Castro E; Méndez-Vidal MJ; Estellés DL; Sarrió RG; Muñoz-Langa J; Herranz UA; Puente Vázquez J; Castellanos E; Hellström M; Widmark A; Lissbrant IF; Jellvert Å; Külich C; Blom R; Chiang PH; Kang CH; Ou YC; Wang SS; Wu HC, 2022, 'Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial', The Lancet Oncology, 23, pp. 362 - 373, http://dx.doi.org/10.1016/S1470-2045(21)00757-9

Sattar S; Menjak IB; Steer C, 2022, 'Supportive and palliative care for older adults with cancer', Current Opinion in Supportive and Palliative Care, 16, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000586

Elbourne H; Soo WK; O’Reilly V; Moran A; Steer CB, 2022, 'Exercise as a supportive care strategy in men with prostate cancer receiving androgen deprivation therapy at a regional cancer centre: a survey of patients and clinicians', Supportive Care in Cancer, 30, pp. 1379 - 1389, http://dx.doi.org/10.1007/s00520-021-06512-2

Peters S; Pujol JL; Dafni U; Dómine M; Popat S; Reck M; Andrade J; Becker A; Moro-Sibilot D; Curioni-Fontecedro A; Molinier O; Nackaerts K; Insa Mollá A; Gervais R; López Vivanco G; Madelaine J; Mazieres J; Faehling M; Griesinger F; Majem M; González Larriba JL; Provencio Pulla M; Vervita K; Roschitzki-Voser H; Ruepp B; Mitchell P; Stahel RA; Le Pechoux C; De Ruysscher D; Hiltbrunner A; Pardo-Contreras M; Gasca-Ruchti A; Giacomelli N; Kammler R; Marti N; Pfister R; Piguet AC; Roux S; Troesch S; Schneider M; Schweri R; Zigomo I; Tsourti Z; Zygoura P; Tsouprou S; Kassapian M; Dimopoulou G; Andriakopoulou C; Morin F; Amour E; Mariaule G; Archirel N; Fernandez M; Pereira E; Benito L; Lopez K; Hernández A; Chinchen S; Jurkovic H; Livingstone A; Mitchell J; Walker M; Ng S; Steer C; Briscoe K; Saqib A; Abdi E; Houghton B; O'Byrne K; Chittajallu BR; Hughes BG; Black A; Werner H; Zalcman G; Vaylet F; Merle P; Monnet I; Girard N; Souquet PJ; Barlesi F; Debieuvre D; Senellart H; Poudenx M; Dixmier A; Pouessel D; Cadranel J; Lena H; Quoix E; Friard S; Audigier-Valette C; Pichon E; Kokowski K; Kirchen H; Tufman A; De-Colle C; de Langen J; Insa A; Massutí B; Pulla MP; Aix SP, 2022, 'Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial', Annals of Oncology, 33, pp. 67 - 79, http://dx.doi.org/10.1016/j.annonc.2021.09.011

Kelly R; Wong SSL; Shapiro J; Weickhardt AJ; Parente P; Azad A; Uccellini A; Torres J; Parnis F; Kwan E; Brown S; Steer C; Warren M; Gibbs P; Anton A; Tran B, 2022, '165P Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer', Annals of Oncology, 33, pp. S1498 - S1499, http://dx.doi.org/10.1016/j.annonc.2022.10.202

Steer C; Jayasuriya D; Webb N; Young K; Rasekaba T; Kapur M; Blackberry I, 2022, 'Geriatric Assessment in the instagram Era: The Addition of Patient Derived Photographs and Photovoice Discussion to an Electronic Geriatric Assessment to Enhance the Supportive Care of Older Adults with Cancer', Journal of Geriatric Oncology, 13, pp. S57 - S57, http://dx.doi.org/10.1016/s1879-4068(22)00379-4

Siu HWD; Tebbutt N; Chantrill L; Karapetis C; Steer C; Wilson K; Espinoza D; Bailey L; Yip S; Cuff J; Pavlakis N; Thavaneswaran S; Briscoe K; Srivastav R; Shannon J; Segelov E; Tie J; Caird S; Francesconi A; Price T; Wuttke M; Ladwa R; Sjoquist K; Burge M, 2021, 'MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08644-4

Rosko AE; Steer C; Chien LC; Zittel J; Artz A; Chow S; Plotkin E; Dale W; Elias R; Chapman AE, 2021, 'The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation core', Journal of Geriatric Oncology, 12, pp. 1164 - 1165, http://dx.doi.org/10.1016/j.jgo.2021.04.001

Menjak IB; Puts M; Steer C, 2021, 'Supportive and palliative care of older adults with cancer', Current Opinion in Supportive and Palliative Care, 15, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000538

Extermann M; Brain E; Canin B; Cherian MN; Cheung KL; de Glas N; Devi B; Hamaker M; Kanesvaran R; Karnakis T; Kenis C; Musolino N; O'Donovan A; Soto-Perez-de-Celis E; Steer C; Wildiers H, 2021, 'Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative', The Lancet Oncology, 22, pp. e29 - e36, http://dx.doi.org/10.1016/S1470-2045(20)30473-3

Soo WK; King M; Pope A; Steer C; Devitt B; Chua S; Parente P; Davis ID; Dārziņš P, 2021, 'The Elderly Functional Index (ELFI), a patient-reported outcome measure of functional status in patients with cancer: a multicentre, prospective validation study', The Lancet Healthy Longevity, 2, pp. e24 - e33, http://dx.doi.org/10.1016/S2666-7568(20)30036-2

Baldini C; Brain EGC; Rostoft S; Biganzoli L; Goede V; Kanesvaran R; Quoix E; Steer C; Papamichael D; Wildiers H, 2021, '1827P European Society for Medical Oncology (ESMO)/International Society of Geriatric Oncology (SIOG) Joint Working Group (WG) survey on management of older patients with cancer', Annals of Oncology, 32, pp. S1237 - S1238, http://dx.doi.org/10.1016/j.annonc.2021.08.715

Soo W-K; King M; Pope A; Steer CB; Devitt BA; Chua SLL; Parente P; Davis ID; Darzins P, 2020, 'ELderly Functional Index (ELFI): Validation of a self-reported measure of functional status in cancer patients.', Journal of Clinical Oncology, 38, pp. e19126 - e19126, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e19126

Mileshkin LR; Posner A; Pattison A; Balachander S; Etemadmoghadam D; Fellowes A; Wong HL; Dow E; deFazio A; Gao B; Karapetis CS; Singh MS; Collins IM; Steer C; Warren MA; Karanth N; Bowtell D; Prall OWJ; Tothill R, 2020, 'Identifying biomarkers to guide immunotherapy treatment of cancer of unknown primary.', Journal of Clinical Oncology, 38, pp. e15252 - e15252, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e15252

Moth EB; Kiely BE; Martin A; Naganathan V; Della-Fiorentina S; Honeyball F; Zielinski R; Steer C; Mandaliya H; Ragunathan A; Blinman P, 2020, 'Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferences', Journal of Geriatric Oncology, 11, pp. 626 - 632, http://dx.doi.org/10.1016/j.jgo.2019.07.026

Tebbutt NC; Steer CB; Sjoquist KM; Chantrill LA; Karapetis CS; Nott LM; Espinoza D; Oostendorp M; Yip S; Cuff J; Burge ME, 2020, 'MONARCC: A randomized phase II study of panitumumab monotherapy and panitumumab (pan) plus 5 Fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer (mCRC): An AGITG clinical trial.', Journal of Clinical Oncology, 38, pp. TPS271 - TPS271, http://dx.doi.org/10.1200/jco.2020.38.4_suppl.tps271

Segelov E; Underhill C; Prenen H; Karapetis C; Jackson C; Nott L; Clay T; Pavlakis N; Sabesan S; Heywood E; Steer C; Lethborg C; Gan HK; Yip D; Karanth N; Karikios D; Raina MacIntyre C, 2020, 'Practical considerations for treating patients with cancer in the COVID-19 pandemic', JCO Oncology Practice, 16, pp. 467 - 482, http://dx.doi.org/10.1200/OP.20.00229

Hui D; Paiva CE; Del Fabbro EG; Steer C; Naberhuis J; van de Wetering M; Fernández-Ortega P; Morita T; Suh SY; Bruera E; Mori M, 2019, 'Prognostication in advanced cancer: update and directions for future research', Supportive Care in Cancer, 27, pp. 1973 - 1984, http://dx.doi.org/10.1007/s00520-019-04727-y

Back to profile page